DE69623966T2 - Verfahren zur herstellung von enantiomerenreinen azetdin-2-carbonsäuren - Google Patents
Verfahren zur herstellung von enantiomerenreinen azetdin-2-carbonsäurenInfo
- Publication number
- DE69623966T2 DE69623966T2 DE69623966T DE69623966T DE69623966T2 DE 69623966 T2 DE69623966 T2 DE 69623966T2 DE 69623966 T DE69623966 T DE 69623966T DE 69623966 T DE69623966 T DE 69623966T DE 69623966 T2 DE69623966 T2 DE 69623966T2
- Authority
- DE
- Germany
- Prior art keywords
- azeoh
- process according
- tartrate
- azetidine
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- IADUEWIQBXOCDZ-VKHMYHEASA-N Azetidine-2-carboxylic acid Natural products OC(=O)[C@@H]1CCN1 IADUEWIQBXOCDZ-VKHMYHEASA-N 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 38
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 claims description 12
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000011975 tartaric acid Substances 0.000 claims description 11
- 235000002906 tartaric acid Nutrition 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000012456 homogeneous solution Substances 0.000 claims description 7
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 claims description 6
- 238000010956 selective crystallization Methods 0.000 claims description 5
- IADUEWIQBXOCDZ-GSVOUGTGSA-N (R)-azetidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCN1 IADUEWIQBXOCDZ-GSVOUGTGSA-N 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- FEWJPZIEWOKRBE-LWMBPPNESA-L D-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O FEWJPZIEWOKRBE-LWMBPPNESA-L 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims 2
- 150000004292 cyclic ethers Chemical class 0.000 claims 1
- 229960001270 d- tartaric acid Drugs 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- -1 N-tosyl-protected L-methionine Chemical class 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 229960001367 tartaric acid Drugs 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- MWIXENPCUPDSOS-QMMMGPOBSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanehydrazide Chemical compound NNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWIXENPCUPDSOS-QMMMGPOBSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003892 tartrate salts Chemical class 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- OGNSCSPNOLGXSM-VKHMYHEASA-N L-2,4-diaminobutyric acid Chemical compound NCC[C@H](N)C(O)=O OGNSCSPNOLGXSM-VKHMYHEASA-N 0.000 description 1
- QJPWUUJVYOJNMH-VKHMYHEASA-N L-homoserine lactone Chemical compound N[C@H]1CCOC1=O QJPWUUJVYOJNMH-VKHMYHEASA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016337 monopotassium tartrate Nutrition 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- 229940086065 potassium hydrogentartrate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9502381A SE9502381D0 (sv) | 1995-06-30 | 1995-06-30 | Process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
| SE9600435A SE9600435D0 (sv) | 1996-02-06 | 1996-02-06 | Process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
| PCT/SE1996/000826 WO1997002241A1 (en) | 1995-06-30 | 1996-06-24 | Process for the production of enantiomerically-pure azetidine-2-carboxylic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69623966D1 DE69623966D1 (de) | 2002-10-31 |
| DE69623966T2 true DE69623966T2 (de) | 2003-08-07 |
Family
ID=26662332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69623966T Expired - Lifetime DE69623966T2 (de) | 1995-06-30 | 1996-06-24 | Verfahren zur herstellung von enantiomerenreinen azetdin-2-carbonsäuren |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5942630A (OSRAM) |
| EP (1) | EP0840724B1 (OSRAM) |
| JP (2) | JP4167726B2 (OSRAM) |
| KR (1) | KR100441571B1 (OSRAM) |
| CN (1) | CN100439333C (OSRAM) |
| AR (2) | AR002573A1 (OSRAM) |
| AT (1) | ATE224871T1 (OSRAM) |
| AU (1) | AU699338B2 (OSRAM) |
| BR (1) | BR9609451A (OSRAM) |
| CA (1) | CA2225896C (OSRAM) |
| CZ (1) | CZ388397A3 (OSRAM) |
| DE (1) | DE69623966T2 (OSRAM) |
| DK (1) | DK0840724T3 (OSRAM) |
| EE (1) | EE03393B1 (OSRAM) |
| ES (1) | ES2181899T3 (OSRAM) |
| HU (1) | HUP9901713A3 (OSRAM) |
| IL (1) | IL122708A (OSRAM) |
| IN (1) | IN187238B (OSRAM) |
| IS (1) | IS4636A (OSRAM) |
| MY (1) | MY132147A (OSRAM) |
| NO (1) | NO308949B1 (OSRAM) |
| NZ (1) | NZ311834A (OSRAM) |
| PL (1) | PL324403A1 (OSRAM) |
| PT (1) | PT840724E (OSRAM) |
| RU (1) | RU2163595C2 (OSRAM) |
| SK (1) | SK179097A3 (OSRAM) |
| TR (1) | TR199701742T1 (OSRAM) |
| TW (1) | TW338035B (OSRAM) |
| WO (1) | WO1997002241A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN187238B (OSRAM) * | 1995-06-30 | 2002-03-09 | Astra Ab | |
| SE9601600D0 (sv) * | 1996-04-26 | 1996-04-26 | Astra Ab | Improved process |
| EP0855446B1 (en) * | 1997-01-24 | 2003-04-09 | Sumitomo Chemical Company, Limited | Process for producing optically active azetidine-2-carboxylic acid derivative |
| JP3757629B2 (ja) * | 1998-07-17 | 2006-03-22 | 住友化学株式会社 | 光学活性ｎ−置換アゼチジン−２−カルボン酸化合物の製造方法 |
| SE9802939D0 (sv) | 1998-09-01 | 1998-09-01 | Astra Ab | New process |
| SE9901712D0 (sv) | 1999-05-11 | 1999-05-11 | Astra Ab | New process |
| DE60039299D1 (de) | 1999-05-14 | 2008-08-07 | Kaneka Corp | Verfahren zur herstellung von optisch aktiven azetidin-2-carbonsäuren |
| JP2000344739A (ja) | 1999-06-01 | 2000-12-12 | Sumitomo Chem Co Ltd | Ｎ−保護−アゼチジン−２−カルボン酸の製造方法 |
| CN100334206C (zh) * | 2002-02-28 | 2007-08-29 | 三菱化学株式会社 | 新型脱氢酶和编码该脱氢酶的基因 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE435499B (sv) * | 1974-12-13 | 1984-10-01 | Merck & Co Inc | Diastereomert salt av s-1-t-butylamino-2,3-dihydroxipropan |
| JPS56104866A (en) * | 1980-01-24 | 1981-08-20 | Mitsubishi Chem Ind Ltd | Production of (2r,4r)-4-alkyl-2-piperidinecarboxylic acid or its l-tartarate salt |
| FR2610323B1 (fr) * | 1987-02-04 | 1989-06-23 | Delalande Sa | Enantiomeres de configuration absolue s de derives amide de l'amino-3 quinuclidine, leur procede de preparation et leur application en therapeutique |
| GB2206880B (en) * | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
| IT1231158B (it) * | 1989-07-20 | 1991-11-19 | Dompe Farmaceutici Spa | Procedimento per la risoluzione ottica della dropropizina. |
| JPH04108774A (ja) * | 1990-08-25 | 1992-04-09 | Mitsubishi Kasei Corp | 光学活性なｎ―インダニルニコチン酸アミド誘導体及びこれを有効成分とする農園芸用殺菌剤 |
| US5095014A (en) * | 1990-12-07 | 1992-03-10 | A. H. Robins Company, Incorporated | 3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity |
| JPH05286933A (ja) * | 1992-04-10 | 1993-11-02 | Dai Ichi Seiyaku Co Ltd | アザスピロオクタン誘導体の塩 |
| FR2690161B1 (fr) * | 1992-04-16 | 1995-06-30 | Esteve Labor Dr | Derives de pyridone azetidinyl substitues avec activite antimicrobienne. |
| IN187238B (OSRAM) * | 1995-06-30 | 2002-03-09 | Astra Ab |
-
1996
- 1996-06-17 IN IN1325DE1996 patent/IN187238B/en unknown
- 1996-06-21 AR ARP960103279A patent/AR002573A1/es unknown
- 1996-06-24 AU AU63232/96A patent/AU699338B2/en not_active Ceased
- 1996-06-24 EE EE9700353A patent/EE03393B1/xx unknown
- 1996-06-24 DK DK96922327T patent/DK0840724T3/da active
- 1996-06-24 ES ES96922327T patent/ES2181899T3/es not_active Expired - Lifetime
- 1996-06-24 CZ CZ973883A patent/CZ388397A3/cs unknown
- 1996-06-24 US US08/716,388 patent/US5942630A/en not_active Expired - Fee Related
- 1996-06-24 PL PL96324403A patent/PL324403A1/xx unknown
- 1996-06-24 EP EP96922327A patent/EP0840724B1/en not_active Expired - Lifetime
- 1996-06-24 JP JP50505797A patent/JP4167726B2/ja not_active Expired - Fee Related
- 1996-06-24 SK SK1790-97A patent/SK179097A3/sk unknown
- 1996-06-24 KR KR1019970709849A patent/KR100441571B1/ko not_active Expired - Fee Related
- 1996-06-24 HU HU9901713A patent/HUP9901713A3/hu unknown
- 1996-06-24 PT PT96922327T patent/PT840724E/pt unknown
- 1996-06-24 BR BR9609451A patent/BR9609451A/pt not_active IP Right Cessation
- 1996-06-24 CN CNB961951133A patent/CN100439333C/zh not_active Expired - Fee Related
- 1996-06-24 IL IL12270896A patent/IL122708A/xx not_active IP Right Cessation
- 1996-06-24 WO PCT/SE1996/000826 patent/WO1997002241A1/en not_active Ceased
- 1996-06-24 DE DE69623966T patent/DE69623966T2/de not_active Expired - Lifetime
- 1996-06-24 TR TR97/01742T patent/TR199701742T1/xx unknown
- 1996-06-24 AT AT96922327T patent/ATE224871T1/de not_active IP Right Cessation
- 1996-06-24 NZ NZ311834A patent/NZ311834A/en not_active IP Right Cessation
- 1996-06-24 CA CA002225896A patent/CA2225896C/en not_active Expired - Fee Related
- 1996-06-24 RU RU98101507/04A patent/RU2163595C2/ru active
- 1996-06-29 MY MYPI96002683A patent/MY132147A/en unknown
- 1996-08-15 TW TW085109938A patent/TW338035B/zh active
-
1997
- 1997-04-18 AR ARP970101587A patent/AR006711A2/es unknown
- 1997-12-19 IS IS4636A patent/IS4636A/is unknown
- 1997-12-23 NO NO976056A patent/NO308949B1/no not_active IP Right Cessation
-
2008
- 2008-05-14 JP JP2008127145A patent/JP2008247922A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2857828C2 (OSRAM) | ||
| EP1147075B1 (de) | Verfahren zur herstellung von l-phenylephrinhydrochlorid | |
| DE69619067T2 (de) | Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten | |
| JP2008247922A (ja) | エナンチオマーとして純粋なアゼチジン−２−カルボン酸の製造方法 | |
| AT392781B (de) | Verfahren zur herstellung von (s)-alpha-ethyl-2- oxo-1-pyrrolidinacetamid | |
| DE69704708T2 (de) | Verfahren zur herstellung von enantiomerenreiner azetidin-carbonsäure | |
| DE3711911A1 (de) | Optisch aktive (alpha)-aminoaldehyde, verfahren zu ihrer herstellung und ihre verwendung zur stereoselektiven herstellung optisch aktiver ss-aminoalkohole | |
| DE69007245T2 (de) | Aminobutanolderivate und Verfahren zur Herstellung von 3-Pyrrolidinol aus diesen. | |
| DE4124283A1 (de) | Umesterung von peptiden | |
| DE60011739T2 (de) | Kristallines oder kristallisiertes Säureadditionssalz von Losartan und Verfahren zur Reinigung von Losartan | |
| DE60002303T2 (de) | Verfahren zur herstellung von paroxetin | |
| DE60105216T2 (de) | Herstellungsverfahren für ein aromatisches Carbonsäurederivat | |
| DE69926642T2 (de) | Verfahren zur herstellung von n-geschützten azetidin-2-carbonsäuren | |
| DE4425071A1 (de) | Verfahren zur Herstellung optisch aktiver Pyrrolidine mit hoher Enantiomerenreinheit | |
| EP0279781A2 (de) | Verfahren zur Herstellung von 4-Acetoxy-3-hydroxyethyl-azetidinon | |
| DE69823506T2 (de) | Verfahren zur herstellung von 3-(7-amidino-2-naphthyl)-2-phenylpropionsäure-derivaten | |
| DE69514115T2 (de) | Verfahren zur herstellung von levobupivacain und analogue aus l-lysin | |
| DE69604247T2 (de) | 2-Cyanopiperazin und ihre Verwendung für die Synthese von biologisch wirksamen Stoffen | |
| EP0073052B1 (de) | Verfahren zur Trennung des Racemats S-(Carboxymethyl)-(RS)-cystein (A) | |
| EP0105243B1 (de) | Spaltung von rac. 1-Propyl-3-aryl-piperidinen | |
| DE2612615A1 (de) | Verfahren zur herstellung von optisch aktivem alpha-phenylglycin und zwischenprodukt dafuer | |
| DE69327092T2 (de) | Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung | |
| DD301797A7 (de) | Verfahren zur Herstellung der optischen Isomeren von1-(4-Nitrophenoxy)-2-Hydroxy-3-tert.-butylamino-propan | |
| DE3134106A1 (de) | Verfahren zur trennung des racemats s-(carboxymethyl)-(r,s)-cystein (b) | |
| DE10207376A1 (de) | Verfahren zur Herstellung von 2-Anilino-4,6-dimethylpyrimidin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |